Skip to content
Screener

CorMedix CRMD Net margin

Net margin at other companies

Pfizer logo
PfizerPFE
15.7%
Merck & Co. logo
Merck & Co.MRK
4.8%-21.0pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9%+0.2pp
IAR
Integra LifeSciencesIART
-0.4%
ICU Medical logo
ICU MedicalICUI
-0.3%-0.2pp
TFX
TeleflexTFX
-45.8%-56.9pp

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$583.68M-22.4%
P/E3.2×
P/S1.5×-4.7×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on trailing twelve months.

The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 8:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001410098-26-000021

FAQ

What is CorMedix's net margin?
CorMedix (CRMD) reported net margin of 45.2% in Q1 2026.
What is the long-term trend for CorMedix's net margin?
Over 3 years (2020 to 2025), CorMedix's net margin has grown at a -82.2% compound annual growth rate (CAGR), from -9,207.7% to 52.3%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about CorMedix's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude